0001127602-15-030341.txt : 20151104 0001127602-15-030341.hdr.sgml : 20151104 20151104173600 ACCESSION NUMBER: 0001127602-15-030341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151102 FILED AS OF DATE: 20151104 DATE AS OF CHANGE: 20151104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stejbach Mark CENTRAL INDEX KEY: 0001487937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 151198089 MAIL ADDRESS: STREET 1: C/O TENGION, INC. STREET 2: 2900 POTSHOP LANE, SUITE 100 CITY: EAST NORRITON STATE: PA ZIP: 19403 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-11-02 0001520262 Alkermes plc. ALKS 0001487937 Stejbach Mark 852 WINTER ST. WALTHAM MA 02451 1 Chief Commercial Officer Ordinary Shares 2015-11-02 4 M 0 18000 17.30 A 37964 D Ordinary Shares 2015-11-02 4 S 0 15670 71.9993 D 22294 D Ordinary Shares 2015-11-02 4 S 0 2330 72.5062 D 19964 D Employee Stock Option (Right to Buy) 17.30 2015-11-02 4 M 0 18000 0 D 2013-03-07 2022-03-07 Ordinary Shares 18000 70440 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.39 to $72.375. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.40 to $72.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing on 3/7/13. /s/ Jennifer Baptiste, attorney-in-fact for Mark Stejbach 2015-11-04